InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (1 oper.)
▼ Ventas (17 oper.)
Historial del iniciado
Director GeneralCompras declaradas
1
Ventas declaradas
17
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the full record of transactions filed by Stueland Katherine, Director General. Insider active across 3 companies, notably GeneDx Holdings Corp.. Cumulatively, 59 disclosures have been recorded. Breakdown: 1 buy · 17 sells. Total volume traded: €4.4m. Activity tracked since 30 April 2021. The latest transaction was filed on 29 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Stueland Katherine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones59 en total
2429 títulosClass A Common StockSEC:0001689575-26-000028:3
18.750 títulosClass A Common StockSEC:0001689575-26-000028:0
2140 títulosClass A Common StockSEC:0001689575-26-000028:1
5932 títulosClass A Common StockSEC:0001689575-26-000028:2
6546 títulosClass A Common StockSEC:0001689575-26-000026:0
3639 títulosClass A Common StockSEC:0001689575-26-000026:1
3874 títulos0Class A Common StockSEC:0001689575-26-000024:0
2154 títulos@ 65,20 US$0.0069% mcap3.8% de su flujoClass A Common StockSEC:0001689575-26-000024:1
18 títulos@ 64,12 US$0.0001% mcap0.0% de su flujoClass A Common StockSEC:0001689575-26-000024:2
80.000 títulos0Class A Common StockSEC:0001689575-26-000021:0
11.921 títulos0Class A Common StockSEC:0001689575-26-000019:0
6546 títulos0Class A Common StockSEC:0001689575-26-000015:0
3404 títulos@ 88,11 US$6.1% de su flujoClass A Common StockSEC:0001689575-26-000013:0
47.684 títulos0Class A Common StockSEC:0001689575-26-000010:0
3874 títulos0Class A Common StockSEC:0001689575-26-000007:0
18.750 títulos0Class A Common StockSEC:0001689575-25-000017:0
6547 títulos0Class A Common StockSEC:0001689575-25-000015:0
3874 títulos0Class A Common StockSEC:0001689575-25-000013:0
606 títulos@ 105,0988 US$1.4% de su flujoClass A Common StockSEC:0001689575-25-000010:0
18.750 títulos0Class A Common StockSEC:0001689575-25-000003:0
6546 títulos0Class A Common StockSEC:0001415889-25-024271:0
3874 títulos0Class A Common StockSEC:0001415889-25-020713:0
3220 títulos@ 93,00 US$6.5% de su flujoClass A Common StockSEC:0001415889-25-019666:0
6928 títulos@ 90,6777 US$14.6% de su flujoClass A Common StockSEC:0001415889-25-019275:0
18.750 títulos0Class A Common StockSEC:0001415889-25-017666:0
25 de 59 declaraciones
About Stueland Katherine
Stueland Katherine is Directeur Général and has reported 59 filings. Across the 59 observed filings, the most recent transactions, from 2021-05-04 to 2026-06-18, show EUR 96455 in purchases and EUR 4265798 in sales, with Levée d'options as the most frequent transaction nature. The main filings relate to GeneDx Holdings Corp. and Invitae Corp.
